购物车
- 全部删除
- 您的购物车当前为空
VISTA-IN-4 (Compound B3) 是一种有效的口服免疫检查点蛋白VISTA抑制剂,KD为0.452 μM。在HepG2细胞中,VISTA-IN-4可将VISTA降解77%(在5 μM浓度下)。该化合物通过激活VISTA介导的免疫抑制来恢复T细胞的活性,并促进细胞因子IL-2的释放。在CT26异种移植小鼠模型中,VISTA-IN-4展示了显著的抗肿瘤活性,且药代动力学特性良好。在SD大鼠中,VISTA-IN-4口服后的血清暴露量适中,AUC(0-t)为412.9 mg·h/mL。
VISTA-IN-4 (Compound B3) 是一种有效的口服免疫检查点蛋白VISTA抑制剂,KD为0.452 μM。在HepG2细胞中,VISTA-IN-4可将VISTA降解77%(在5 μM浓度下)。该化合物通过激活VISTA介导的免疫抑制来恢复T细胞的活性,并促进细胞因子IL-2的释放。在CT26异种移植小鼠模型中,VISTA-IN-4展示了显著的抗肿瘤活性,且药代动力学特性良好。在SD大鼠中,VISTA-IN-4口服后的血清暴露量适中,AUC(0-t)为412.9 mg·h/mL。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 期货 | |
50 mg | 待询 | 期货 |
产品描述 | VISTA-IN-4 (Compound B3) is an orally active inhibitor of the immune checkpoint protein VISTA, with a KD of 0.452 μM. It degrades VISTA in HepG2 cells with a degradation rate of 77% at a concentration of 5 μM. VISTA-IN-4 counteracts VISTA-mediated immune suppression, restoring T cell activity and promoting the release of cytokine IL-2. Additionally, it exhibits antitumor activity in CT26 xenograft mouse models and demonstrates favorable pharmacokinetic properties, with good oral serum exposure in SD rats, reflected by an AUC(0-t) of 412.9 mg·h/mL. |
分子量 | 388.48 |
分子式 | C24H25FN4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容